Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Bought by Ameriprise Financial Inc

Saturday, 13 Jan, 2018

The ROIC Quality of Walgreens Boots Alliance, Inc. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator's stock worth $5,480,577,000 after acquiring an additional 1,926,108 shares during the last quarter. Hedge funds and other institutional investors own 60.09% of the company's stock. Commonwealth Bank of Australia lifted its holdings in Walgreens Boots Alliance by 139.5% in the second quarter. (NASDAQ:WBA) has been trading in a bearish manner, based on the relative positions of the stock's 20 and 200 day moving averages. Capital World Investors increased its stake in shares of Walgreens Boots Alliance by 11.5% in the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator's stock valued at $2,004,000 after buying an additional 10,729 shares in the last quarter. Macquarie Group Ltd.'s holdings in Walgreens Boots Alliance were worth $1,934,000 as of its most recent filing with the Securities & Exchange Commission. BlackRock Investment Management LLC now owns 2,821,496 shares of the pharmacy operator's stock worth $234,946,000 after buying an additional 1,092,180 shares in the last quarter. Bristlecone Advisors LLC bought a new position in Walgreens Boots Alliance in the 3rd quarter worth approximately $135,000. Zions Bancorporation lifted its holdings in Walgreens Boots Alliance by 983.3% during the third quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator's stock worth $156,000 after purchasing an additional 87 shares during the period.

Always volatility measures make charm for active trader; price volatility of stock was 1.81% for a week and 1.62% for a month. The share price has moved forward from its 20 days moving average, trading at a distance of 3.44% and stays 6.02% away from its 50 days moving average.

Any given stock may have anywhere between 1 to 40 brokerage analysts making EPS estimates as they follow the company. It is calculated by multiplying a company's shares outstanding by the current market price of one share. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm's stock in a transaction that occurred on Thursday, November 2nd. Also, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. Following the completion of the transaction, the director now owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. The firm owned 16,174 shares of the pharmacy operator's stock after selling 12,890 shares during the period.

A number of equities research analysts recently issued reports on WBA shares. Raymond James Financial restated a "market perform" rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. Vetr upgraded Walgreens Boots Alliance from a "buy" rating to a "strong-buy" rating in a report on Tuesday, December 12th. (NASDAQ:WBA) received a Buy rating from 4 analysts. Finally, SunTrust Banks set a $72.00 price target on Walgreens Boots Alliance and gave the company a "hold" rating in a report on Sunday, October 15th.

According to the Recommendation Trends of the stock polled by Zacks Investment Research for this month, the company has a consensus recommendation of 1.47 out of the scale from 1 to 5 where 1 stands for Strong Buy and 5 means Strong Sell. Investors who observing the volume trend of Walgreens Boots Alliance, Inc. The MF Rank of Walgreens Boots Alliance, Inc. The company has a market cap of $75,340.00, a price-to-earnings ratio of 21.01, a P/E/G ratio of 1.29 and a beta of 1.22. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. The 52-Week High range of the stock is $117.65, while the 52-week low range is $74.67.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. The Gross Margin Score of Walgreens Boots Alliance, Inc. The business's revenue for the quarter was up 7.9% compared to the same quarter a year ago. Over the last five days, shares have managed 5.28% gains and now is down -2.86% since hitting its 200-day moving average of $75.3. BioCryst Pharmaceuticals, Inc. has 2 buy ratings, 2 holds and 0 sells even after the stock tumbled -38.81% from its high of $9.25 to a $571.83 million market value through last close.

Companies that can consistently grow earnings at a high compound rate usually have the greatest potential to create value for shareholders in the long-run. If you are viewing this report on another publication, it was illegally stolen and republished in violation of worldwide copyright & trademark law. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & global trademark and copyright legislation. The legal version of this story can be viewed at https://www.thelincolnianonline.com/2018/01/13/cubist-systematic-strategies-llc-increases-stake-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company.